As the global small nucleic acid drugs market rapidly expands, driven by growing demand for precise treatments targeting genetic disorders, rare diseases, and cancer. The high specificity of small ...

In small nucleic acid drug development, Tsingke drives innovation in synthesis, modification, delivery, and scale-up. With an end-to-end service model-from sequence design to validation-the company ...

During his tenure at the U.S. Food and Drug Administration (FDA), Dr. Wang ... position in the rapidly evolving field of small nucleic acids. Through its collaboration with Dr. Wang, Tsingke ...